Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of ...

The authors, Prof Peter Lunn along with senior researchers Shane Timmins and Deirdre Robertson, found that while a ...

FDA's reasoning appears to center on a belief that COVID-19 treatment immunobridging analyses for a monoclonal antibody (mAb) must meet a standard of superior antiviral activity rather than equivalent ...

The 78-year-old woman presented was coughing up blood along with a fever, sudden shortness of breath and was found to be in ...

A new analysis of health data from Ontario, Canada, suggests that nirmatrelvir-ritonavir (Paxlovid) may provide limited benefit for vaccinated older adults with COVID-19, despite its previously proven ...

While most children in the State continue to receive vaccines, there has been significant slip in uptake since 2020. This has ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

The antiviral pill Paxlovid does not significantly reduce COVID-19 hospitalizations in vaccinated older adults, according to ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

Still, Mafi says there aren't strong data on how Paxlovid affects the disease course in people who are vaccinated. His findings suggest that the benefits are about four times smaller than those ...

The authors compared outcomes among adults just under 70 years who were not prescribed Paxlovid to those who were given the ...

Bay Area News Group: Berkeley Man Sues Kaiser Permanente, Accuses Medical Assistant Of Sexual Assault During Cancer Surgery A Kaiser Permanente patient filed a lawsuit last week against the ...